Sirio Pharma Statistics

Total Valuation

Sirio Pharma has a market cap or net worth of CNY 5.84 billion. The enterprise value is 6.99 billion.

Market Cap	5.84B
Enterprise Value	6.99B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	May 27, 2025

Share Statistics

Sirio Pharma has 305.96 million shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	305.96M
Shares Outstanding	305.96M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	20.72%
Owned by Institutions (%)	18.21%
Float	111.14M

Valuation Ratios

The trailing PE ratio is 16.87 and the forward PE ratio is 15.40.

PE Ratio	16.87
Forward PE	15.40
PS Ratio	1.31
PB Ratio	2.13
P/TBV Ratio	3.44
P/FCF Ratio	28.33
P/OCF Ratio	8.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.23, with an EV/FCF ratio of 33.90.

EV / Earnings	20.24
EV / Sales	1.57
EV / EBITDA	11.23
EV / EBIT	16.14
EV / FCF	33.90

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.62.

Current Ratio	1.89
Quick Ratio	1.35
Debt / Equity	0.62
Debt / EBITDA	2.74
Debt / FCF	8.27
Interest Coverage	5.94

Financial Efficiency

Return on equity (ROE) is 10.94% and return on invested capital (ROIC) is 10.00%.

Return on Equity (ROE)	10.94%
Return on Assets (ROA)	4.85%
Return on Invested Capital (ROIC)	10.00%
Return on Capital Employed (ROCE)	9.05%
Weighted Average Cost of Capital (WACC)	5.60%
Revenue Per Employee	1.60M
Profits Per Employee	124,470
Employee Count	2,776
Asset Turnover	0.80
Inventory Turnover	5.56

Taxes

In the past 12 months, Sirio Pharma has paid 38.53 million in taxes.

Income Tax	38.53M
Effective Tax Rate	11.69%

Stock Price Statistics

The stock price has decreased by -2.28% in the last 52 weeks. The beta is 0.34, so Sirio Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-2.28%
50-Day Moving Average	20.71
200-Day Moving Average	23.16
Relative Strength Index (RSI)	35.79
Average Volume (20 Days)	2,191,548

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sirio Pharma had revenue of CNY 4.45 billion and earned 345.53 million in profits. Earnings per share was 1.13.

Revenue	4.45B
Gross Profit	1.43B
Operating Income	433.36M
Pretax Income	329.66M
Net Income	345.53M
EBITDA	587.76M
EBIT	433.36M
Earnings Per Share (EPS)	1.13

Full Income Statement

Balance Sheet

The company has 605.41 million in cash and 1.71 billion in debt, giving a net cash position of -1.10 billion or -3.60 per share.

Cash & Cash Equivalents	605.41M
Total Debt	1.71B
Net Cash	-1.10B
Net Cash Per Share	-3.60
Equity (Book Value)	2.75B
Book Value Per Share	8.69
Working Capital	972.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 695.53 million and capital expenditures -489.27 million, giving a free cash flow of 206.27 million.

Operating Cash Flow	695.53M
Capital Expenditures	-489.27M
Depreciation & Amortization	154.40M
Net Borrowing	-40.38M
Free Cash Flow	206.27M
FCF Per Share	0.67

Full Cash Flow Statement

Margins

Gross margin is 32.11%, with operating and profit margins of 9.73% and 7.76%.

Gross Margin	32.11%
Operating Margin	9.73%
Pretax Margin	7.40%
Profit Margin	7.76%
EBITDA Margin	13.20%
EBIT Margin	9.73%
FCF Margin	4.63%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.67%.

Dividend Per Share	0.13
Dividend Yield	0.67%
Dividend Growth (YoY)	-23.18%
Years of Dividend Growth	n/a
Payout Ratio	49.89%
Buyback Yield	-0.24%
Shareholder Yield	0.43%
Earnings Yield	5.91%
FCF Yield	3.53%

Dividend Details

Stock Splits

The last stock split was on May 27, 2025. It was a forward split with a ratio of 1.3.

Last Split Date	May 27, 2025
Split Type	Forward
Split Ratio	1.3

Scores

Altman Z-Score	n/a
Piotroski F-Score	5